Clearance of Persistent Methicillin-Susceptible Staphylococcus lugdunensis Bacteremia Using Nafcillin Plus Ertapenem Combination Therapy

被引:0
|
作者
Sharma, Ishrya [1 ]
Hodges, Jacqueline [1 ]
Moonah, Shannon [1 ]
Shirley, Debbie-Ann [2 ]
机构
[1] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA
[2] Univ Virginia, Dept Pediat, Div Pediat Infect Dis, Charlottesville, VA USA
关键词
bacteremia; ertapenem; S; lugdunensis; ENDOCARDITIS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Staphylococcus lugdunensis is a coagulase-negative staphylococcus that can cause serious infection similar to Staphylococcus aureus. Limited therapeutic options are available for patients with staphylococcal bacteremia who fail to respond to standard monotherapy, particularly when source control of infection is not feasible, driving the need for improved synergistic antibiotic combinations to enhance medical management. We present the case of a 58-year-old patient with persistent S. lugdunensis bacteremia for over 1 week despite appropriate therapy with nafcillin. Blood cultures were successfully sterilized following the addition of ertapenem salvage therapy, with rapid blood culture clearance within 2 days of initiation. To our knowledge, this is the first report of using ertapenem in combination with an antistaphylococcal penicillin to specifically clear persistent S. lugdunensis bacteremia. Similar success has been reported using this combination to treat methicillin-susceptible S. aureus infections; hence, our report provides further support for the benefit of this combination for staphylococcal infections.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] CEFTAROLINE AS SALVAGE THERAPY FOR METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS COMPLICATED BACTEREMIA
    Obed, Mora N.
    Toresani, Ines
    Mykietuk, Analia
    Nannini, Esteban C.
    MEDICINA-BUENOS AIRES, 2022, 82 (05) : 794 - 797
  • [42] Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia
    Kufel, Wesley D.
    Parsels, Katie A.
    Blaine, Bruce E.
    Steele, Jeffrey M.
    Mahapatra, Rahul
    Paolino, Kristopher M.
    Thomas, Stephen J.
    PHARMACOTHERAPY, 2023, 43 (01): : 15 - 23
  • [43] Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan
    Tsuzuki, S.
    Yu, J.
    Matsunaga, N.
    Ohmagari, N.
    PUBLIC HEALTH, 2021, 198 : 292 - 296
  • [44] Vancomycin plus nafcillin salvage for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia following daptomycin failure: a case report and literature review
    Lewis, Paul O.
    Sevinsky, Regan E.
    Patel, Paras D.
    Krolikowski, Matthew R.
    Cluck, David B.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2019, 6
  • [45] Whole-genome sequencing to explore nosocomial transmission and virulence in neonatal methicillin-susceptible Staphylococcus aureus bacteremia
    Bibi C. G. C. Slingerland
    Margreet C. Vos
    Willeke Bras
    René F. Kornelisse
    Dieter De Coninck
    Alex van Belkum
    Irwin K. M. Reiss
    Wil H. F. Goessens
    Corné H. W. Klaassen
    Nelianne J. Verkaik
    Antimicrobial Resistance & Infection Control, 9
  • [46] Whole-genome sequencing to explore nosocomial transmission and virulence in neonatal methicillin-susceptible Staphylococcus aureus bacteremia
    Slingerland, Bibi C. G. C.
    Vos, Margreet C.
    Bras, Willeke
    Kornelisse, Rene F.
    De Coninck, Dieter
    Van Belkum, Alex
    Reiss, Irwin K. M.
    Goessens, Wil H. F.
    Klaassen, Corne H. W.
    Verkaik, Nelianne J.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2020, 9 (01)
  • [47] Updates on Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia
    Alison L. Blackman
    Ellen C. Rubin
    Eleanor K. Broadbent
    Karrine D. Brade
    Current Infectious Disease Reports, 2020, 22
  • [48] The Role of Combination Therapy in Critically Ill Patients With Methicillin-susceptible Staphylococcus aureus Bloodstream Infections: Does The Question Remain? Reply
    Cheng, Matthew P.
    Lawandi, Alexander
    Butler-Laporte, Guillaume
    De l'Etoile-Morel, Samuel
    Paquette, Katryn
    Lee, Todd C.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (01) : 168 - 169
  • [49] Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection
    Beganovic, Maya
    Cusumano, Jaclyn A.
    Lopes, Vrishali
    LaPlante, Kerry L.
    Caffrey, Aisling R.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (07):
  • [50] Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone
    Winans, S. A.
    Luce, A. M.
    Hasbun, R.
    INFECTION, 2013, 41 (04) : 769 - 774